-
Evaluation of the new commercial recombinant chimeric subunit vaccine PRRSFREE in challenge with heterologous types 1 and 2 porcine reproductive and respiratory syndrome virusEvaluation of the new commercial recombi...
-
The valid period of PRRSFREE PRRS subunit vaccine has been extend from 24 months to 36 monthsThe valid period of PRRSFREE PRRS subuni...
This site uses cookies to improve your browsing experience. By continuing to browse this site you are agreeing to our use of cookies. For further information, please refer to Privacy Policy.
